Cargando…

Correction: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma

Detalles Bibliográficos
Autores principales:	Gruber, Elisabeth S., Jomrich, Gerd, Tamandl, Dietmar, Gnant, Michael, Schindl, Martin, Sahora, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771687/ https://www.ncbi.nlm.nih.gov/pubmed/33373414 http://dx.doi.org/10.1371/journal.pone.0244896

Ejemplares similares

Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma
por: Gruber, Elisabeth S., et al.
Publicado: (2019)

The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection
por: Gruber, Elisabeth S., et al.
Publicado: (2020)

Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection
por: Jomrich, Gerd, et al.
Publicado: (2019)

Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Kim, Dong Wook, et al.
Publicado: (2022)

Sarcopenia and Sarcopenic Obesity
por: Choi, Kyung Mook
Publicado: (2013)

Sarcopenia and sarcopenic obesity
por: Choi, Kyung Mook
Publicado: (2016)

The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer
por: Gruber, Elisabeth S., et al.
Publicado: (2019)

Surgery for chronic pancreatitis: the comparison of two high-volume centers reveals lack of a uniform operative management
por: Surci, Niccolò, et al.
Publicado: (2021)

Long-Term Follow-Up after Surgery for Chronic Pancreatitis: A Bicentric Retrospective Experience
por: Surci, Niccolò, et al.
Publicado: (2023)

Erratum: Gruber, E.S.; et al. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer. Cells 2019, 8, 1357
por: Gruber, Elisabeth S., et al.
Publicado: (2020)

Editorial: (Osteo)Sarcopenia & sarcopenic obesity
por: Masiero, Stefano, et al.
Publicado: (2023)

Sarcopenia and Sarcopenic Obesity in Patients with Muscular Dystrophy
por: Merlini, Luciano, et al.
Publicado: (2014)

Inflammatory response and oxidative stress during liver resection
por: Schwarz, Christoph, et al.
Publicado: (2017)

Sarcopenia and Sarcopenic Obesity in Patients Undergoing Orthopedic Surgery
por: Ji, Hyung-Min, et al.
Publicado: (2016)

Uncertainty and Diversity in the Methods Defining Sarcopenia and Sarcopenic Obesity
por: Kim, Kyoung Min
Publicado: (2017)

The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer
por: Şahin, Muzaffer Ece Hakan, et al.
Publicado: (2023)

Editorial: (Osteo)sarcopenia & sarcopenic obesity, volume II
por: Kostoglou-Athanassiou, Ifigenia, et al.
Publicado: (2023)

Sarcopenia, obesity and sarcopenic obesity: effects on liver function and volume in patients scheduled for major liver resection
por: Lodewick, Toine M, et al.
Publicado: (2015)

The Role of Visceral Obesity, Sarcopenia and Sarcopenic Obesity on Surgical Outcomes After Liver Resections for Colorectal Metastases
por: Runkel, M., et al.
Publicado: (2021)

Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
por: Ei, Shigenori, et al.
Publicado: (2023)

Randomized clinical trial of the effect of a fibrin sealant patch on pancreatic fistula formation after pancreatoduodenectomy
por: Schindl, M., et al.
Publicado: (2018)

Respiratory Sarcopenia and Sarcopenic Respiratory Disability: Concepts, Diagnosis, and Treatment
por: Nagano, A., et al.
Publicado: (2021)

Applied precision medicine in metastatic pancreatic ductal adenocarcinoma
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
por: Ormanns, Steffen, et al.
Publicado: (2015)

Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
por: Flis, Vojko, et al.
Publicado: (2016)

Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
por: Lekka, Kyriaki, et al.
Publicado: (2019)

Contemporary Review of Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Bonds, Morgan, et al.
Publicado: (2019)

Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma
por: Cao, Ying-Ying, et al.
Publicado: (2023)

Author’s Reply: The Role of Visceral Obesity, Sarcopenia and Sarcopenic Obesity on Surgical Outcomes After Liver Resections for Colorectal Metastases
por: Runkel, Mira
Publicado: (2021)

Additive Value of Preoperative Sarcopenia and Lymphopenia for Prognosis Prediction in Localized Pancreatic Ductal Adenocarcinoma
por: d’Engremont, Christelle, et al.
Publicado: (2021)

CT Body Composition of Sarcopenia and Sarcopenic Obesity: Predictors of Postoperative Complications and Survival in Patients with Locally Advanced Esophageal Adenocarcinoma
por: Fehrenbach, Uli, et al.
Publicado: (2021)

Characterization of Ageing- and Diet-Related Swine Models of Sarcopenia and Sarcopenic Obesity
por: Garcia-Contreras, Consolacion, et al.
Publicado: (2018)

Association between Sarcopenia, Sarcopenic Obesity, and Chronic Disease in Korean Elderly
por: Lim, Hee-Sook, et al.
Publicado: (2018)

Prevalence of Sarcopenia and Sarcopenic Obesity in an Academic Total Joint Arthroplasty Practice
por: DeMik, David E., et al.
Publicado: (2022)

The impact of sarcopenia and sarcopenic obesity on survival in children with Ewing sarcoma and osteosarcoma
por: Buğdaycı, Onur, et al.
Publicado: (2023)

Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection
por: Chen, Haoda, et al.
Publicado: (2021)

Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
por: Buc, Emmanuel, et al.
Publicado: (2014)

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Jiang, Hui, et al.
Publicado: (2013)

Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma
por: Lohneis, Philipp, et al.
Publicado: (2018)

The borderline resectable and locally advanced pancreatic ductal adenocarcinoma: Definition
por: Soweid, Assaad M.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_epak0055q5nkpkns5pl4d7ob6m